In the News January 31, 2019

The Deal | Alexion, Caelum Collaborate

Alston & Bird is noted for representing Fortress Biotech, Inc., and Caelum Biosciences Inc. in a deal with Alexion Pharmaceuticals Inc. to develop a treatment for a rare systemic disorder.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.